Literature DB >> 8595152

Curing gastric cancer--hone the scalpel with magic?

A Webb, D Cunningham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8595152      PMCID： PMC2074447          DOI： 10.1038/bjc.1996.74

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.

Authors:  H Imanaga; H Nakazato
Journal:  World J Surg       Date:  1977-03       Impact factor: 3.352

2.  Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.

Authors:  J Hermans; J J Bonenkamp; M C Boon; A M Bunt; S Ohyama; M Sasako; C J Van de Velde
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

3.  Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

Authors:  J A Wils; H O Klein; D J Wagener; H Bleiberg; H Reis; F Korsten; T Conroy; M Fickers; S Leyvraz; M Buyse
Journal:  J Clin Oncol       Date:  1991-05       Impact factor: 44.544

4.  FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

Authors:  D Kelsen; O T Atiq; L Saltz; D Niedzwiecki; D Ginn; D Chapman; R Heelan; C Lightdale; V Vinciguerra; M Brennan
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

5.  Gastric cancer: a 25-year review.

Authors:  W H Allum; D J Powell; C C McConkey; J W Fielding
Journal:  Br J Surg       Date:  1989-06       Impact factor: 6.939

6.  Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C.

Authors:  T Nakajima; A Fukami; I Ohashi; T Kajitani
Journal:  Int J Clin Pharmacol Biopharm       Date:  1978-05

7.  Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients.

Authors:  J J Grau; J Estapé; F Alcobendas; C Pera; M Daniels; J Terés
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

8.  A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

Authors:  M Findlay; D Cunningham; A Norman; J Mansi; M Nicolson; T Hickish; V Nicolson; A Nash; N Sacks; H Ford
Journal:  Ann Oncol       Date:  1994-09       Impact factor: 32.976

9.  Epidoxorubicin and high dose leucovorin plus 5-fluorouracil in advanced gastric cancer: a phase II study.

Authors:  B Neri; M T Gemelli; D Pantalone; F Andreoli; S Bruno; S Fabbroni; V Leone; A Valeri; D Borrelli
Journal:  Anticancer Drugs       Date:  1993-06       Impact factor: 2.248

10.  Clinicopathological staging of gastric cancer.

Authors:  J W Fielding; C Roginski; D J Ellis; B G Jones; J Powell; J A Waterhouse; V S Brookes
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939
View more
  1 in total

1.  Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment.

Authors:  M Schauer; M Peiper; J Theisen; W Knoefel
Journal:  Eur J Med Res       Date:  2011-01-27       Impact factor: 2.175
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.